Our work identified the PKM1-AMPK-NFYa axis in energetic regulation of cardiomyocyte proliferation during heart development, and may provide novel targets for energetic intervention for congenital heart diseases with cardiomyocyte proliferation defects. This evidence concerns the gene NFYA and congenital heart disease.